Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI3 Energy Regulatory News (I3E)

  • This share is currently suspended. It was suspended at a price of 12.74
  • There is currently no data for I3E

Amended Loan Note Terms

6 Feb 2018 11:00

RNS Number : 0423E
i3 Energy PLC
06 February 2018
 

6 February 2018

 

i3 Energy plc

("i3" or the "Company")

 

Amended Loan Note Terms

 

 

i3 Energy plc, an independent oil and gas company with assets and operations in the UK is pleased to announce it has entered into an agreement to amend the terms of the existing loan notes (the "Existing Loan Notes") subscribed by James Caird Asset Management (the "Noteholder"). As previously set out in the Company's IPO Admission Document, the Loan Notes are for the amount of US$2,500,000 and are automatically convertible into new ordinary shares if the Company raises at least $20million of new equity post IPO (a "Relevant Fundraising"). The conversion price in the event of a Relevant Fundraising is the lower of: (i) 75% of the subscription price paid per Ordinary Share pursuant to the Relevant Fundraising or: (ii) 54 cents per Ordinary Share (approx. 39p at the current exchange rate).

 

The amended loan note instrument supercedes the existing loan note instrument dated 17 July 2017 and the principal amendments to the Existing Loan Notes are as follows:

· Under the Existing Loan Notes, the Company may not: (i) incur any borrowings exceeding US$4,950,000; or (ii) create, or permit to subsist, any security without the consent of the Noteholder. The former of these has been removed in the amended loan note instrument, and the latter has been amended such that "security" for the purposes of the undertaking shall not include any security granted for the purpose of securing any obligation of the Company in relation to any financing or borrowing provided to the Company to fund the development of its oil and gas assets. These amendments and relaxation of these provisions provides the Company with greater flexibility to negotiate terms for the potential joint venture and other financing arrangements currently under discussion. 

· Where an equity fundraising by the Company raises less than US$20 million of new money, the Noteholder shall be entitled to convert a pro-rata proportion of the amended Loan Notes (such that, for the avoidance of doubt, if a fundraising raises US$15 million, the Noteholder would be entitled to convert 75% of the amended Loan Notes) at a conversion price per Ordinary Share equal to 75% of the subscription price per Ordinary Share pursuant to such fundraising. 

· In the event that the Company serves notice on the Noteholder of its intention to redeem the amended Loan Notes in cash, the Noteholder has the right to elect for all of the amended Loan Notes to instead convert into Ordinary Shares at a conversion price per Ordinary Share equal to the volume weighted average price of the Ordinary Shares over the five business days immediately preceding the date on which the redemption notice is served by the Company.  

· The maturity date of the Loan Notes is 18 August 2018 (as per the Existing Loan Notes).

Pursuant to the foregoing amendments, following completion of the Company's recent placing of new Ordinary Shares raising ÂŁ2.57m, the Noteholder becomes entitled to convert US$451,614 of the amended Loan Notes into 1,427,271 new Ordinary Shares at a price per new Ordinary Share of US$0.3164 (being 75% of the subscription price per new Ordinary Share under the Company's recent placing of new Ordinary Shares raising ÂŁ2.57m, and using an exchange rate of GBP1:US$1.4063). The Company will additionally convert c.US$48,386 of the amended Loan Notes at US$0.54 per Ordinary Share (approx. 39p at the current exchange rate), bringing the total resulting converted shares to 1,516,876 (the "Conversion Shares"). The outstanding value of the Loan Notes post this conversion will be US$2,000,000.

The directors of the Company intend to call a general meeting of the Company within the next few days (such meeting to take place on or around the end of February) seeking, among other things, authority from shareholders to issue the Conversion Shares.

ENDS

 

 

CONTACT DETAILS:

 

i3 Energy plc

 

 

Neill Carson (CEO) / Graham Heath (CFO)

c/o Camarco

Tel: +44 (0) 203 757 4980

 

WH Ireland Limited (Nomad and Joint Broker)

 

 

James Joyce, James Sinclair-Ford

Tel: +44 (0) 207 220 1666

 

 

GMP FirstEnergy (Joint Broker)

 

 

Jonathan Wright, David van Erp

Tel: +44 (0) 207 448 0200

 

 

Camarco

Georgia Edmonds, Jane Glover, James Crothers

 

Tel: +44 (0) 203 757 4980

 

 

Notes to Editors:

i3 is an oil and gas development company initially focused on the North Sea. The Company's core asset is the Liberator oil field discovered by well 13/23d-8 located in License P.1987, Block 13/23d in which it has a 100% operated interest.

 

The Company's strategy is to acquire high quality, low risk producing and development assets, to broaden its portfolio and grow its reserves and production.

 

i3 has a strong management team with a track record of delivery and was founded by Neill Carson, previously founder and CEO of Ithaca Energy, where he built an asset portfolio including multiple developments.

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBGGDDSDGBGIL
Date   Source Headline
28th Sep 202111:25 amRNSH1 2021 Earnings Webcast
27th Sep 20214:44 pmRNSPresentation
27th Sep 20217:00 amRNSInterim Report and Dividend Declaration
16th Sep 20217:00 amRNSNotice of Half Year 2021 Results and Webcast
15th Sep 20219:53 amRNSWarrant Exercise and Share Issuance
9th Sep 20217:00 amRNSOperational Update
2nd Sep 20213:59 pmRNSHolding(s) in Company
2nd Sep 20213:58 pmRNSHolding(s) in Company
23rd Aug 20217:00 amRNSClosing of Previously Announced Acquisition
16th Aug 20217:00 amRNSOperational and Financial Update
30th Jul 20216:16 pmRNSIssue of Share Options
29th Jul 20217:00 amRNSOperational Update
28th Jul 20214:58 pmRNSHolding(s) in Company
28th Jul 20214:57 pmRNSHolding(s) in Company
28th Jul 20214:55 pmRNSHolding(s) in Company
27th Jul 20213:05 pmRNSAdmission to Trading of Share Capital
26th Jul 202111:25 amRNSResult of General Meeting
15th Jul 20218:37 amRNSOperational Update
9th Jul 20214:38 pmRNSPosting of Shareholder Circular & Options Issuance
8th Jul 20217:01 amRNSNew Corporate Presentation
8th Jul 20217:00 amRNSDividend Declaration
7th Jul 20218:17 amRNSResults of Accelerated Bookbuild
7th Jul 20217:01 amRNSPrimaryBid Offer
7th Jul 20217:00 amRNSAlberta Acquisition and Proposed Placing
6th Jul 20214:40 pmRNSSecond Price Monitoring Extn
6th Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20217:00 amRNSOperational Update
1st Jul 20217:29 amRNSResult of AGM
30th Jun 20217:00 amRNSCapital Restructuring and Wapiti Acquisition
28th Jun 20217:00 amRNSOperational Update
17th Jun 20217:01 amRNSOperational & Dividend Update & Prod. Acquisition
17th Jun 20217:00 amRNSi3 Canada Ltd YE 2020 Reserves
3rd Jun 202111:53 amRNSResult of General Meeting
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20217:15 amRNSFinal Results for the year ended 31 December 2020
1st Jun 20217:00 amRNSSouth Simonette Consolidation – ROFR Exercise
18th May 20219:31 amRNSReduction of Capital
17th May 20217:00 amRNSContract Restructure & Dividend Creditor Consent
5th May 20217:00 amRNSOperational and Financial Update
29th Apr 20218:56 amRNSExercise of Options and Share Issuance
22nd Apr 20215:11 pmRNSHolding(s) in Company
16th Apr 20217:00 amRNSWarrant Exercise and Share Issuance
7th Apr 20213:49 pmRNSHolding(s) in Company
31st Mar 20217:00 amRNSOperational and Financial Update
23rd Mar 20213:15 pmRNSHolding(s) in Company
16th Mar 20213:17 pmRNSHolding(s) in Company
24th Feb 20219:05 amRNSSecond Price Monitoring Extn
24th Feb 20219:00 amRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.